Pipeline update from Ocuphire

Dec 26, 2022

Phentolamine improved distance-corrected near visual acuity

Dec 20, 2022

Treatment of Presbyopia: One of Several Potential Indications for Nyxol

Dec 1, 2022

Ocuphire partners with Viatris for marketing, commercialization of Nyxol eye drop

Nov 19, 2022

Presbyopia Physician November eUpdate

Nov 10, 2022

Ocuphire initiates Global License Agreement for Nyxol eye drops across 3 indications

Nov 8, 2022

Ocuphire reaches license agreement for the development and commercialization of Nyxol

Nov 8, 2022

Ocuphire enters global license agreement with Famy for Nyxol development

Nov 8, 2022

Ocuphire Enters into a Global License Agreement for Development and Commercialization of Nyxol Eye Drops

Nov 7, 2022

Presbyopia: How are the Drops Performing?

Jul 10, 2022

• « Previous
• 1
• 2
• 3
• 4
• 5
• 6
• Next »